Gene Context Sentence

Table 2. Analysis of context sentence of VIT gene in 6 abstracts.

PMID Gene Context Sentence
32322486 Intravenous (IV) Vitamin C (Vit-C) has emerged as one of the other alternatives for this purpose. […] Here we review the effects of IV Vit-C on the immune system response, the antiviral properties of IV Vit-C, and finally the antioxidant properties of IV Vit-C to specifically address the cytokines’ storm characteristic of the Acute Respiratory Distress Syndrome (ARDS) that occur in the later cycle of the Covid19 infectious disease.
32582329 There is no evidence found that supplement can cure the immune system except Vit C, which is one of the best way to improve immune system.
32904593 Here, we hypothesize that a single large dose of vitamin D (Vit D) could be an option for trial in COVID-19. […] Vit D deficiency or insufficiency is very common in the general population as well as in patients with COVID-19. […] It has been shown that low Vit D level is associated with viral infection, and Vit D supplementation is beneficial for people infected with viruses, such as HIV and hepatitis C virus. […] Clinical studies have shown that Vit D can exert anticoagulant effects. […] Vit D, a lipid-soluble vitamin, can be administered as a draught. […] Vit D supplementation is safe and has rare toxic events. […] In addition, the cost of Vit D is fairly low. […] Based on these observations, we speculate that a single dose of 300,000 IU Vit D may have a role in the prevention and treatment of COVID-19.
33138949 The manuscript “Covid-19 And Vit-D: Disease Mortality Negatively Correlates with Sunlight Exposure” held our attention as we found fatal shortcomings that invalidates the analyses and conclusions.
33224428 We evaluated the frequency and severity of COVID-19 infection in a cohort of 211 subjects referring to our center for the regular administration of venom immunotherapy (VIT). […] We reported only an isolated positivity of COVID-19 in the overall group; whereas none suffered from upper airway symptoms associated with COVID-19 (fever, cough, dyspnoea, sore throat, anosmia, and/or ageusia). […] Even though the demographic characteristics pose a substantial risk for such a population, we suggest that a regular administration of VIT may help in the development of an immunological milieu able to down modulate the Th1/Th17 environment that has been linked to inflammatory manifestations of COVID-19. […] To the best of our knowledge, this is the first description of the incidence of COVID-19 infection in Hymenoptera venom allergic patients treated with VIT, suggesting indirectly that venom immune tolerance-inducing treatment may be capable of reducing the aberrant inflammatory response induced by the virus in this specific population.
33249121 According to expert consensus, the time interval between Hymenoptera venom immunotherapy (VIT) injections can be extended up to 12 weeks, without significant impact on efficacy and safety. […] To provide advice on how to resume VIT safely after a long delay from the last injection considering the potential risk factors for side effects, without starting again with the induction phase. […] All the patients who delayed VIT because of the pandemic were consecutively enrolled in this single-center study. […] The time extension was decided according to their risk profile (eg, long prepandemic time interval, severe pre-VIT reaction, older age, multitreatments), and correlation analyses were performed to find potential risk factors of side effects. […] The mean delay from the pre- (7 weeks) to the postpandemic VIT interval (15.5 weeks) was 8.5 weeks. […] The total amount of the prepandemic VIT maintenance dose was safely administered in 1 day in 78% of patients, whereas only 3, of 87, experienced side effects, and their potential risk factors were identified in bee venom allergy and recent VIT initiation. […] In a real-world setting, long VIT delays may be safe and well tolerated, but more caution should be paid in resuming VIT in patients with long prepandemic maintenance interval, severe pre-VIT reaction, recent VIT initiation, older age, multidrug treatments, and bee venom allergy. […] This is useful in any case of long, unplanned, and unavoidable VIT delay.